Table 1.
Suggested mechanisms to explain the possible positive effects of metformin on COVID-19 outcomes.
| Mechanisms | References |
|---|---|
| Improved glucose control | Ceriello et al. [5], [6] |
| Reduction in body weight | El-Arabey and Abdalla [20] |
| Reduction in insulin resistance | Penlioglou et al. [16] Sharma et al. [17] |
| AMPK activation leads to phosphorylation of ACE2, thereby inhibition of virus penetration | Sharma et al. [17] |
| Inhibition of mTOR pathway and prevention of immune hyperactivation | Sharma et al. [17] Bolourian and Mojtahedi [21] Lehrer [22] |
| Action on endosomal Na+/H+ exchanger, thereby increasing cellular pH and interference with viral endocytic cycle | Esam [23] |
| Anti-inflammatory properties | Kumar Singh and Singh [18] |
| Reduction in neutrophils | Dalan [24] |
| Inhibition of mitochondrial complex 1, suppression of mitochondrial reactive oxygen species (ROS) signalling, ROS prevention: CRAC-mediated interleukin-6 release | Menendez [25] |
AMPK: AMP-activated protein kinase; ACE2: angiotensin-converting enzyme 2; mTOR: mammalian target of rapamycin; CRAC: Ca2+ release-activated Ca2+ channels.